BlackRock, Inc. 13D and 13G filings for AcelRx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BlackRock Inc. BLK | 113,302 1.900% | -168,745 (-59.83%) | Filing |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | BlackRock Inc. BLK | 282,047 5.700% | 1,446 (+0.52%) | Filing |